sodium selenite has been researched along with Benign Neoplasms in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (11.11) | 18.2507 |
| 2000's | 8 (44.44) | 29.6817 |
| 2010's | 6 (33.33) | 24.3611 |
| 2020's | 2 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, MC; Chung, AS; Kim, SJ; Park, JM | 1 |
| Garcia-Cremades, M; Jayachandran, P; Knox, SJ; Savić, RM | 1 |
| Chen, P; Wu, X; Yang, CS; Zhang, J; Zhang, L; Zhao, G | 1 |
| Aitken, JB; Finney, L; Harris, HH; Vogt, S; Weekley, CM; Witting, PK | 1 |
| Asker-Hagelberg, C; Björnstedt, M; Brodin, O; Eksborg, S; Jacobsson, H; Larsen, EH; Lenneby-Helleday, C; Linder, S; Misra, S; Mohlkert, D; Wallenberg, M | 1 |
| Echigo, S; Endo, M; Rikiishi, H; Shinohara, F; Suzuki, M | 1 |
| Cheng, WH; Kang, MM; Schoene, NW; Wu, M | 1 |
| Brozmanová, J; Chovanec, M; Mániková, D; Vlčková, V | 1 |
| Abdullaev, F; Caballero-Salazar, S; Ordaz-Tellez, MG; Riverón-Negrete, L | 1 |
| Lipinski, B | 1 |
| Dennert, G; Horneber, M | 1 |
| Popova, M; Savcheva, M | 1 |
| Bruns, F; Büntzel, J; Kisters, K; Micke, O; Mücke, R | 1 |
| Allen, MJ; Damron, TA; Margulies, BS | 1 |
| Berggren, M; Gallegos, A; Gasdaska, JR; Powis, G | 1 |
| Ip, C | 1 |
| Schrauzer, GN | 1 |
| Kasseroller, RG; Schrauzer, GN | 1 |
6 review(s) available for sodium selenite and Benign Neoplasms
| Article | Year |
|---|---|
Antitumor Effects of Selenium.
Topics: Antineoplastic Agents; Glutathione; Humans; Methanol; Neoplasms; Organoselenium Compounds; Selenium Compounds; Sodium Selenite | 2021 |
Selenium metabolism in cancer cells: the combined application of XAS and XFM techniques to the problem of selenium speciation in biological systems.
Topics: Animals; Copper; Fluorescence; Humans; Microscopy, Fluorescence; Neoplasms; Organoselenium Compounds; Selenium; Selenocysteine; Selenomethionine; Sodium Selenite; X-Ray Absorption Spectroscopy | 2013 |
Selenium: a double-edged sword for defense and offence in cancer.
Topics: Antioxidants; Apoptosis; Cell Cycle; Dietary Supplements; DNA Damage; DNA Repair; Humans; Neoplasms; Oxidative Stress; Reactive Oxygen Species; Saccharomyces cerevisiae; Selenium; Selenium Compounds; Sodium Selenite | 2010 |
Selenium for alleviating the side effects of chemotherapy, radiotherapy and surgery in cancer patients.
Topics: Antineoplastic Agents; Antioxidants; Diarrhea; Humans; Lymphedema; Neoplasms; Postoperative Complications; Radiotherapy; Randomized Controlled Trials as Topic; Sodium Selenite | 2006 |
Lessons from basic research in selenium and cancer prevention.
Topics: Anticarcinogenic Agents; Dietary Supplements; Garlic; Humans; Methylation; Neoplasms; Plants, Medicinal; Selenium; Sodium Selenite | 1998 |
Nutritional selenium supplements: product types, quality, and safety.
Topics: Anticarcinogenic Agents; Antioxidants; Biological Availability; Consumer Product Safety; Dietary Supplements; Humans; Neoplasms; No-Observed-Adverse-Effect Level; Nutritional Requirements; Selenic Acid; Selenium; Selenium Compounds; Selenomethionine; Sodium Selenite | 2001 |
2 trial(s) available for sodium selenite and Benign Neoplasms
| Article | Year |
|---|---|
Clinical Pharmacokinetics of Oral Sodium Selenite and Dosing Implications in the Treatment of Patients with Metastatic Cancer.
Topics: Administration, Oral; Biological Availability; Humans; Male; Neoplasms; Selenious Acid; Sodium Selenite | 2021 |
Pharmacokinetics and Toxicity of Sodium Selenite in the Treatment of Patients with Carcinoma in a Phase I Clinical Trial: The SECAR Study.
Topics: Administration, Intravenous; Adult; Aged; Antineoplastic Agents; Biomarkers; Dose-Response Relationship, Drug; Drug Administration Schedule; Endpoint Determination; Fatigue; Female; Humans; Male; Maximum Tolerated Dose; Middle Aged; Nausea; Neoplasms; Sodium Selenite; Treatment Outcome | 2015 |
10 other study(ies) available for sodium selenite and Benign Neoplasms
| Article | Year |
|---|---|
Selenium nanoparticles are more efficient than sodium selenite in producing reactive oxygen species and hyper-accumulation of selenium nanoparticles in cancer cells generates potent therapeutic effects.
Topics: Animals; Cell Line, Tumor; Glutathione; Humans; Metal Nanoparticles; Mice; Neoplasms; Oxidation-Reduction; Reactive Oxygen Species; Selenium; Sodium Selenite | 2018 |
Differential apoptotic response of human cancer cells to organoselenium compounds.
Topics: Anticarcinogenic Agents; Apoptosis; Blotting, Western; Caspase 3; Caspase 8; Caspase 9; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cysteine; Flow Cytometry; Humans; Neoplasms; Organoselenium Compounds; Selenocysteine; Selenomethionine; Sodium Selenite; Tumor Suppressor Protein p53 | 2010 |
Selenium compounds activate early barriers of tumorigenesis.
Topics: Anticarcinogenic Agents; Antioxidants; Ataxia Telangiectasia Mutated Proteins; Cell Cycle Proteins; Cell Line; Cell Line, Tumor; Cellular Senescence; Cysteine; DNA Damage; DNA Repair; DNA-Binding Proteins; Histones; Humans; Male; Neoplasms; Organoselenium Compounds; Oxidative Stress; Protein Serine-Threonine Kinases; Reactive Oxygen Species; Selenium Compounds; Selenocysteine; Sodium Selenite; Tumor Suppressor Proteins | 2010 |
The combination of natural and synthetic agents--a new pharmacological approach in cancer chemoprevention.
Topics: Antineoplastic Agents, Phytogenic; Arsenites; Crocus; HeLa Cells; Humans; Neoplasms; Neoplastic Stem Cells; Plant Extracts; Sodium Selenite; Tumor Cells, Cultured | 2002 |
Rationale for the treatment of cancer with sodium selenite.
Topics: Humans; Neoplasms; Oxidation-Reduction; Sodium Selenite | 2005 |
[Sodium selenite (Cefasel-Libra Ag) in obstetrics and gynecology].
Topics: Drug Administration Schedule; Female; Gynecology; Humans; Neoplasms; Obstetrics; Selenium; Sodium Selenite | 2006 |
Some clinical results on selenium in radiation oncology: letter by O. Micke, R. Mücke, F. Bruns, K. Kisters, J. Büntzel on W. Dörr: Effects of selenium on radiation responses of tumor cells and tissue in: Strahlenther Onkol 2006;182:693-5 (No. 12) (DOI 10
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Humans; Male; Middle Aged; Neoplasms; Premedication; Radiation Injuries; Radiation-Protective Agents; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Selenium; Sodium Selenite; Survival Rate; Uterine Neoplasms | 2007 |
The differential effects of the radioprotectant drugs amifostine and sodium selenite treatment in combination with radiation therapy on constituent bone cells, Ewing's sarcoma of bone tumor cells, and rhabdomyosarcoma tumor cells in vitro.
Topics: Amifostine; Animals; Bone Neoplasms; Cell Line, Tumor; Cell Survival; Drug Screening Assays, Antitumor; Gamma Rays; Humans; Mice; Neoplasms; Osteoblasts; Radiation-Protective Agents; Rats; Rhabdomyosarcoma; Sarcoma, Ewing; Sodium Selenite; Soft Tissue Neoplasms | 2008 |
Mechanisms of the regulation of thioredoxin reductase activity in cancer cells by the chemopreventive agent selenium.
Topics: Anticarcinogenic Agents; Culture Media, Serum-Free; Dose-Response Relationship, Drug; Humans; Neoplasm Proteins; Neoplasms; RNA, Messenger; Sodium Selenite; Thioredoxin-Disulfide Reductase; Thioredoxins; Tumor Cells, Cultured | 1997 |
Treatment of secondary lymphedema of the arm with physical decongestive therapy and sodium selenite: a review.
Topics: Arm; Clinical Trials as Topic; Combined Modality Therapy; Humans; Lymphedema; Neoplasms; Physical Therapy Modalities; Sodium Selenite | 2000 |